$2.67 Billion is the total value of Rubric Capital Management LP's 61 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COOP | MR COOPER GROUP INC | $105,254,666 | +5.8% | 1,965,173 | 0.0% | 3.95% | -7.2% | |
| AIR | AAR CORP | $73,127,962 | +3.1% | 1,228,422 | 0.0% | 2.74% | -9.6% | |
| ANIP | ANI PHARMACEUTICALS INC | $49,177,459 | +7.9% | 847,011 | 0.0% | 1.84% | -5.4% | |
| HOLI | HOLLYSYS AUTOMATION TCHNGY L | $38,514,142 | +12.8% | 1,941,237 | 0.0% | 1.44% | -1.0% | |
| OVID | OVID THERAPEUTICS INC | $20,912,294 | +17.1% | 5,445,910 | 0.0% | 0.78% | +2.6% | |
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $14,984,795 | -2.3% | 11,616,120 | 0.0% | 0.56% | -14.3% | |
| TRVI | TREVI THERAPEUTICS INC | $12,392,036 | -8.8% | 5,684,420 | 0.0% | 0.46% | -20.0% | |
| FTAI INFRASTRUCTURE INC | $10,283,167 | -12.7% | 3,193,530 | 0.0% | 0.39% | -23.4% | ||
| MX | MAGNACHIP SEMICONDUCTOR CORP | $8,042,975 | -25.7% | 967,867 | 0.0% | 0.30% | -34.8% | |
| MYPS | PLAYSTUDIOS INC | $6,236,565 | -35.2% | 1,961,184 | 0.0% | 0.23% | -43.2% | |
| CGEM | CULLINAN ONCOLOGY INC | $5,673,707 | -15.9% | 626,929 | 0.0% | 0.21% | -26.0% | |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $4,126,948 | -21.3% | 205,423 | 0.0% | 0.16% | -30.8% | |
| HOWL | WEREWOLF THERAPEUTICS INC | $4,141,664 | -29.8% | 1,935,357 | 0.0% | 0.16% | -38.5% | |
| THERAPEUTICSMD INC | $3,600,417 | -26.7% | 1,192,191 | 0.0% | 0.14% | -35.7% | ||
| VINC | VINCERX PHARMA INC | $357,921 | -22.3% | 354,377 | 0.0% | 0.01% | -35.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
| BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
| MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
| PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
| RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
| HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
| COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
| AAR CORP | 14 | Q3 2023 | 3.2% |
| GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
| Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
| BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
| EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
| Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
| Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
| Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
| Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
| Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
| ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| DFAN14A | 2024-05-03 |
| DFAN14A | 2024-05-01 |
| DFAN14A | 2024-04-30 |
| DFAN14A | 2024-04-29 |
| DEFC14A | 2024-04-17 |
| DFAN14A | 2024-04-17 |
| SC 13D/A | 2024-04-16 |
| PRRN14A | 2024-04-02 |
| PRRN14A | 2024-03-26 |
| DFAN14A | 2024-03-11 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.